BRI-50460
Product Specifications
Target
Phospholipase
Related Pathways
Metabolism
Bioactivity
BRI-50460 is an inhibitor of cytosolic calcium-dependent phospholipase A2 (cPLA2) with the ability to cross the blood-brain barrier, exhibiting an IC50 of 0.88 nM. By inhibiting cPLA2, BRI-50460 modulates downstream inflammatory lipid signaling pathways, mitigating the effects of amyloid β42 oligomers on cPLA2 activation, tau protein hyperphosphorylation, and synaptic and dendritic loss. This results in its activity in regulating neuroinflammation and restoring lipid homeostasis. BRI-50460 is applicable in research related to Alzheimer's disease and other neurodegenerative disorders.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6206518-01 0.1 mL
GTF3C3 (General Transcription Factor IIIC, Polypeptide 3, 102kD, TFIIIC102, TFIIICgamma, TFiiiC2-102) (MaxLight 490)
Sign In for Pricing
View Details MBS6206518-02 5x 0.1 mL
GTF3C3 (General Transcription Factor IIIC, Polypeptide 3, 102kD, TFIIIC102, TFIIICgamma, TFiiiC2-102) (MaxLight 490)
Sign In for Pricing
View Details